Skip to content
Nonprofiteer
← SOCIETY FOR IMMUNOTHERAPY OF CANCER INC

Form 990 for tax year 2023

Filed by SOCIETY FOR IMMUNOTHERAPY OF CANCER INC.

Totals

Total revenue
$15,211,563
Total expenses
$15,284,371
Contributions and grants received
$3,448,837
Grants paid
$750,180
Program service revenue
$11,184,715
Investment income
$366,609
Other revenue
$211,402
Total assets, end of year
$22,459,068
Total liabilities, end of year
$1,454,218
Net assets or fund balances, end of year
$21,004,850
Program services expenses (Part IX)
$13,368,325
Management and general expenses
$1,836,476
Fundraising expenses
$79,570
Program service expenses (Part III)
$13,368,325

Program services were 87.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $3,448,837

  • 2a · Program service revenue: ANNUAL MEETING

    total $7,560,761 · related or exempt $7,560,761

  • 2b · Program service revenue: MEMBERSHIP DUES & ASSESSMENTS

    total $1,774,705 · related or exempt $1,774,705

  • 2c · Program service revenue: PUBLISHER REVENUE

    total $431,298 · related or exempt $431,298

  • 2d · Program service revenue: WORKSHOP

    total $298,496 · related or exempt $298,496

  • 2e · Program service revenue: PRIMER

    total $295,965 · related or exempt $295,965

  • 2f · All other program service revenue

    total $823,490 · related or exempt $823,490

  • 3 · Investment income

    total $366,609 · excluded $366,609

  • 5 · Royalties

    total $1,680 · excluded $1,680

  • 8a · Fundraising events: gross income

    $75,852

  • 8b · Fundraising events: direct expenses

    $45,320

  • 8c · Net income from fundraising events

    total $30,532 · excluded $30,532

  • 10a · Gross sales of inventory

    $3,385

  • 10b · Cost of goods sold

    $6,151

  • 10c · Net income from sales of inventory

    total -$2,766 · related or exempt -$2,766

  • 11a · Other revenue: ADVERTISING

    total $91,500 · unrelated business $91,500

  • 11b · Other revenue: MISCELLANEOUS

    total $90,456 · related or exempt $90,456

  • 11e · Other revenue, total

    $181,956

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $660,000 · program services $660,000

  • 2 · Grants to domestic individuals

    total $7,000 · program services $7,000

  • 3 · Grants to foreign organizations and individuals

    total $83,180 · program services $83,180

  • 5 · Compensation of officers, directors and key employees

    total $14,750 · program services $14,750

  • 11a · Fees: management

    total $6,371,114 · program services $5,225,020 · management and general $1,134,094 · fundraising $12,000

  • 11b · Fees: legal

    total $4,088 · management and general $4,088

  • 11c · Fees: accounting

    total $17,250 · management and general $17,250

  • 11f · Fees: investment management

    total $23,539 · management and general $23,539

  • 11g · Fees: other

    total $193,285 · program services $193,285

  • 12 · Advertising and promotion

    total $313,446 · program services $250,702 · management and general $60,800 · fundraising $1,944

  • 13 · Office expenses

    total $51,478 · program services $12,535 · management and general $18,998 · fundraising $19,945

  • 14 · Information technology

    total $442,541 · program services $297,702 · management and general $144,839

  • 17 · Travel

    total $573,401 · program services $481,449 · management and general $91,952

  • 19 · Conferences, conventions and meetings

    total $5,992,367 · program services $5,807,757 · management and general $141,548 · fundraising $43,062

  • 23 · Insurance

    total $11,180 · program services $7,286 · management and general $3,894

  • 24a · Other expenses: BANK AND CC FEES

    total $259,646 · program services $225,453 · management and general $32,324 · fundraising $1,869

  • 24b · Other expenses: EXHIBITING

    total $118,353 · program services $28,654 · management and general $89,699

  • 24c · Other expenses: MISCELLANEOUS

    total $95,017 · program services $47,649 · management and general $47,368

  • 24d · Other expenses: MEMBERSHIP ACTIVITIES

    total $27,015 · program services $25,903 · management and general $362 · fundraising $750

  • 24e · All other expenses

    total $25,721 · management and general $25,721

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $9,541,641 · end of year $5,615,756

  • 2 · Savings and temporary cash investments

    beginning of year $6,520,387 · end of year $6,637,682

  • 3 · Pledges and grants receivable

    beginning of year $181,000 · end of year $435,000

  • 4 · Accounts receivable

    beginning of year $332,055 · end of year $202,254

  • 8 · Inventories for sale or use

    beginning of year $4,483 · end of year $2,220

  • 9 · Prepaid expenses and deferred charges

    beginning of year $148,639 · end of year $415,828

  • 10a · Land, buildings and equipment: cost or other basis

    $28,836

  • 10b · Land, buildings and equipment: accumulated depreciation

    $28,836

  • 10c · Land, buildings and equipment, net

    beginning of year $0 · end of year $0

  • 11 · Investments: publicly traded securities

    beginning of year $7,578,556 · end of year $9,133,809

  • 12 · Investments: other securities

    end of year $16,519

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,046,074 · end of year $146,563

  • 19 · Deferred revenue

    beginning of year $1,860,470 · end of year $1,307,655

  • 27 · Net assets without donor restrictions

    beginning of year $18,294,652 · end of year $18,096,662

  • 28 · Net assets with donor restrictions

    beginning of year $2,105,565 · end of year $2,908,188

Mission and programs · 2023

Mission

TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE.

  • THE SOCIETY FOR IMMUNOTHERAPY OF CANCER'S (SITC) 38TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2023) PROVIDED A MULTIDISCIPLINARY EDUCATIONAL AND INTERACTIVE ENVIRONMENT FOCUSED ON IMPROVING THE OUTCOME FOR CURRENT AND FUTURE PATIENTS WITH CANCER BY INCORPORATING STRATEGIES BASED ON BASIC AND APPLIED CANCER IMMUNOTHERAPY. THE ANNUAL MEETING CONSISTED OF CUTTING-EDGE RESEARCH PRESENTATIONS BY EXPERTS IN THE FIELD, ORAL AND POSTER ABSTRACT PRESENTATIONS AND AMPLE OPPORTUNITY FOR STRUCTURED AND INFORMAL DISCUSSIONS, INCLUDING IMPORTANT NETWORKING OPPORTUNITIES. IN ADDITION, THE MEETING INCLUDES UPDATES ON MAJOR NATIONAL AND INTERNATIONAL INITIATIVES COMING FROM ACADEMIA, GOVERNMENT AND INDUSTRY, AS WELL AS IMPORTANT SOCIETY PROJECTS.

    Expenses $7,826,434 · Revenue $7,652,262

  • SITC'S FORWARD FUND IS AN INITIATIVE ESTABLISHED BY SITC IN 2012 TO STIMULATE THE FUTURE OF THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH FINANCIALLY SUPPORTING ITS EDUCATION AND RESEARCH. SINCE INCEPTION, THE FORWARD FUND HAS AWARDED MORE THAN $5 MILLION TOWARD PROGRAMS, GRANTS AND INITIATIVES THAT SUPPORT EARLY CAREER SCIENTISTS THROUGH RESEARCH AND EDUCATION. FROM THE GENEROSITY OF OUR DONORS, HUNDREDS OF EARLY CAREER SCIENTISTS' CAREERS HAVE BEEN SHAPED BY THE FORWARD FUND. BY PROVIDING FELLOWSHIPS, YOUNG INVESTIGATOR AWARDS AND THE ONE-OF-A-KIND SITC SPARKATHON, SITC IS INSPIRING THE NEXT GENERATION, ADVANCING THE SCIENCE AND TACKLING THE HURDLES FACING THE FIELD.

    Expenses $716,000 · Grants $716,000

  • THE ADVANCES IN CANCER IMMUNOTHERAPY (ACI) SERIES HOSTED FIFTEEN CME-, CNE- AND CPE-CERTIFIED PROGRAMS IN 2023. SIX OF THE PROGRAMS WERE HELD IN PERSON AND STREAMED VIRTUALLY, AND NINE OF THE PROGRAMS WERE HELD VIRTUALLY ONLY. THE SERIES ALSO FEATURED EIGHT ONLINE INTERACTIVE COURSES AND FIVE SPECIALTY WEBINARS. THE SERIES WAS DESIGNED TO PROVIDE EDUCATION TO PATIENT CARE PROVIDERS AND OTHERS WHO WISH TO LEARN THE BASIC PRINCIPLES OF TUMOR IMMUNOLOGY AND IMMUNOTHERAPY, AND TO IMPROVE THEIR ABILITY TO INTEGRATE IMMUNOTHERAPY INTO STATE-OF-THE-ART CLINICAL MANAGEMENT FOR THEIR PATIENTS. THIS INTENDED AUDIENCE INCLUDED CLINICAL ONCOLOGISTS, REGISTERED NURSES, NURSE PRACTITIONERS, PHARMACISTS, EMERGENCY PHYSICIANS, ALLIED HEALTH PROFESSIONALS, OTHER PATIENT CARE PROVIDERS, STUDENTS AND PATIENT ADVOCATES.

    Expenses $984,497 · Revenue $103,230

  • WORKSHOP / CONNECTED / PRIMER / WIC/ INDUSTRY / WINTER / WIN / SPAKATHON PROGRAM / JOURNAL / COLLABORATIVE EDUCATION PROGRAMS / CIG / POLICY ACTIVITIES / SCIENTIFIC RESOURCES / CERTIFICATE PROGRAM / DIVERSITY, EQUITY AND INCLUSION / ENGINEERING AND IO / FAIO / OTHER PROGRAM SERVICES

    Expenses $3,153,291 · Revenue $3,516,913

  • CIG PROGRAM - THE SITC CANCER IMMUNOTHERAPY GUIDELINES PROGRAM IS A COLLECTION OF CLINICAL PRACTICE GUIDELINES (CPGS) DEVELOPED BY MULTI-DISCIPLINARY PANELS OF EXPERTS WHO DRAW FROM THEIR OWN PRACTICAL EXPERIENCE AS WELL AS EVIDENCE IN THE PUBLISHED LITERATURE AND CLINICAL TRIAL DATA TO DEVELOP EVIDENCE- AND CONSENSUS-BASED RECOMMENDATIONS ON WHEN AND HOW TO USE IMMUNOTHERAPY TO HELP IMPROVE OUTCOMES FOR PATIENTS WITH CANCER. THESE CPGS OFFER A VITAL RESOURCE FOR THE PRACTICING ONCOLOGY COMMUNITY. SITC USES AS A MODEL THE INSTITUTE OF MEDICINE'S 2011 "STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES" TO ENSURE A FAIR, TRANSPARENT AND BALANCED PROCESS FOR CREATING THE CPGS. EACH CPG EXPERT PANEL IS COMPRISED OF A COMPREHENSIVE MIX OF ACADEMIC PHYSICIANS AND RESEARCHERS, NURSES, PATIENTS, AND PATIENT ADVOCATES INVITED FROM INSTITUTIONS ACROSS THE UNITED STATES.

    Expenses $688,103

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Leisha Emens MD PhD

    PRESIDENT

    Total calculated
    $750
    From this org
    $750
    From related orgs
    $0
    Other
    $0
    Hours/week
    5

  • James Gulley MD PhD

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    5

  • Jedd Wolchok MD PhD

    SECR/TREASURER

    Total calculated
    $0
    Hours/week
    5

  • Patrick Hwu MD

    IMM. PAST PRES.

    Total calculated
    $0
    Hours/week
    5

  • Christian Capitini MD

    DIRECTOR

    Total calculated
    $5,000
    From this org
    $5,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Adekunle Odunsi MD PhD Frcog Faco

    DIRECTOR

    Total calculated
    $2,500
    From this org
    $2,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Ann Silk MD Ms

    DIRECTOR

    Total calculated
    $3,000
    From this org
    $3,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Julie Brahmer MD

    DIRECTOR

    Total calculated
    $500
    From this org
    $500
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Jennifer Guerriero PhD

    DIRECTOR

    Total calculated
    $1,000
    From this org
    $1,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Jennifer Wargo MD Mmsc

    DIRECTOR

    Total calculated
    $2,000
    From this org
    $2,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Jason Luke MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Sarah Warren PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Tulia Bruno PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type
form_990
Tax year
2023
Filed
14 November 2024
IRS schema version
2023v5.1
Source object
202413199349310226

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.